Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spero Therapeutics (2HA.F) Q3 2025 Earnings
2HA.F
12
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.49
-0.34
-0.18
-0.03
Details
Expected EPS
-0.32539399999999996
Actual EPS
-0.025688999999999997
Surprise EPS
0.3
Surprise Percent
+92.11%
Description
Spero Therapeutics (2HA.F) has reported earnings of -0.025688999999999997 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login